In addition to morphological profiling, immunohistochemical analyses for specific markers—including estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/NEU/ERBB2)—have allowed breast tumors to be classified into different subtypes. This evidence concerns the gene PGR and breast neoplasm.